• Vaxil Locations
  • Contact Us
  • News and Updates
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • PIPELINE
  • Investor Center
  • Presentation
  • Covid-19 experiments
  • In the Media

Investor Presentations

To download, please click below.

 

executive summary

exec-one-pager

Vaxil Overview – Executive Summary

 

investor fact-sheet

vaxil-one-pager

Vaxil Immunotherapy – One Page Overview

 

AACR 2017 Poster – Immucin Acts as Novel Neoantigen

Vaxil AACR Poster - Immucin Acts as Novel Neoantigen

Vaxil – AACR Poster – Immucin Acts as True Neoantigen

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, “Weizmann Science Park”, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Center
  • Investor Presentations
  • Public Filings
  • Video
  • Scientific Publications
  • In the Media
Copyright 2020 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • PIPELINE
  • Investor Center
  • Presentation
  • Covid-19 experiments
  • In the Media
  • Vaxil Locations
  • Contact Us
  • News and Updates
  • Subscribe